ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,426Medicare Part D Prescriptions Filled, Including Refills

Rank: 326 out of 890

$303K Total Retail Price of All Prescriptions

Rank: 427 out of 890

335 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

27% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 4,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 550 213 S3 1 3
LOVASTATIN 300 207 2 46
LISINOPRIL 226 170 3 4
METFORMIN HCL 181 94 4 6
LEVOTHYROXINE SODIUM 165 142 5 2
MELOXICAM 161 119 6 18
ALPRAZOLAM 158 85 7 95
FUROSEMIDE 153 93 8 7
ATENOLOL 142 107 9 23
METOPROLOL TARTRATE 137 93 10 15
CLONIDINE HCL 136 96 11 35
ZOLPIDEM TARTRATE 135 88 12 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 103 13 21
SIMVASTATIN 129 129 14 5
NEXIUM 111 56 15 14
AMOXICILLIN 107 57 16 94
PRAVASTATIN SODIUM 103 80 17 10
AMLODIPINE BESYLATE 98 56 18 1
GLIMEPIRIDE 95 84 19 27
GABAPENTIN 92 52 20 12
GLYBURIDE-METFORMIN HCL 91 52 R 21 115
TRAMADOL HCL 82 61 22 16
DIAZEPAM 71 45 23 278
HYDROCHLOROTHIAZIDE 70 36 24 9
CARISOPRODOL 68 0 R 25 69
RANITIDINE HCL 65 43 26 49
PANTOPRAZOLE SODIUM 65 34 26 34
ALLOPURINOL 63 58 28 31
SULINDAC 62 39 29 292
GEMFIBROZIL 62 55 29 103
CITALOPRAM HBR 57 31 31 20
OMEPRAZOLE 55 38 32 8
AMITRIPTYLINE HCL 54 0 R 33 43
CEPHALEXIN 53 37 34 119
OXYCODONE HCL 52 0 S2 35 123
TEMAZEPAM 52 40 35 222
TRAZODONE HCL 52 18 35 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 35 38 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.